Program Description: 

This educational activity is based on case presentations and subsequent small group discussions of patients with hematologic malignancies that are being evaluated, treated and followed in the Department of Hematology and Oncology, and that have diagnostic or follow-up material evaluated in the Division of Hematopathology.  The goal of this multimodality approach is to ensure that the best patient care is being delivered by both Hematologists/Oncologists and Pathologists.

Key Words: CME, MCW, Pathology, Clinical Pathology, Molecular Pathology, Hematologic Neoplasms, Hematologic Tests, Hematologic Diseases, Morphological and Microscopic Findings, Diagnostic Techniques and Procedures, Clinical Laboratory Techniques, Hemic and Immune Systems, Differential Diagnosis, Pathological Processes, Neoplastic Cell Transformation

Target audience: 
Learning objectives: 

Learning objectives are identified for Hematologists/Oncologists and Hematopathologists.

Participants who engage in this educational intervention will be able to: 


  • Identify appropriate ordering of expensive, ancillary diagnostic testing
  • Describe the salient morphologic, immunophenotypic, cytogenetic and molecular features of common hematologic malignancies 


  • Discuss emergent therapeutic options and availability of clinical trials, and how they apply to patients diagnosed in our service
  • Utilize and constantly update themselves with the clinical practices of the Department of Hematology and Oncology, in order to continue to improve outcomes and provide optimal patient care
Faculty & credentials: 

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

  • Alexandra Harrington, MD, MT(ASCP)CM
  • Steven H. Kroft, MD
  • Shannon M. Majewski, CMP, CMM, HMCC, VEMM


In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

Ehab Atallah, MDNovartisConsultant
Ehab Atallah, MDTakedaResearcher; Consultant
Ehab Atallah, MDAbbvieResearcher; Consultant
Ehab Atallah, MDAdaptive BiotechnologiesConsultant
Ehab Atallah, MDFoundation OneAdvisory Board
Ehab Atallah, MDCelgeneConsultant
Ehab Atallah, MDGenentechConsultant
Laura Michaelis, MDJazz PharmaceuticalsClinical Trial
Laura Michaelis, MDSociety of Hematologic OncologyEducational Board Member & Speaker
Laura Michaelis, MDWintrobe's PublishingEditor, Malignant Hematology
Laura Michaelis, MDASHEditor in Chief  of Hematologist; Speaker; Author, National Publications
Laura Michaelis, MDABIMCommittee Member
Laura Michaelis, MDCurio ScienceConsulting, Advisory Board
Laura Michaelis, MDCelgene CorpConsulting, Advisory Board
Laura Michaelis, MDIncyte CorporationReport, Deposition, Civil Litigation Testimony



Shannon Majewski, CMP, CMM, HMCC, VEMM
Phone number: 
+1 (414) 805-6976
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of  Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
MOC Part II Recognition Statement:
American Board of Pathology
American Board of Pathology SAMs
The Medical College of Wisconsin is a provider for Self-Assessment Modules as defined by the American Board of Pathology, and has designated this educational activity for a maximum of 1.0 SAM credits.
Participation shared with ABPath through PARS
Individual participants' information will be shared with ABPath through the ACCME Program and Activity Reporting System (PARS).
American Board of Internal Medicine
Public Information About Activities Registered for ABIM MOC Recognition:
ACCME published information about accredited CME activities that have been registered for ABIM MOC via its CME Finder. CME Finder is a publicly available, online search tool that provides a one-stop resource for physician learners seeking to earn MOC points by participating in accredited CME.
Participation shared with ABIM through PARS:
Individual participants' information will be shared with ABIM through the ACCME Program and Activity Reporting System (PARS).

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit and ABPath MOC credit.



Session date: 
04/21/2021 - 8:00am to 9:00am CDT
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.